A study suggests that the availability of orphan drugs varies significantly between different countries in Europe. Conducted by the University of Finland and published in the European Journal of Clinical Pharmacology, the study focused on […]
Research carried out by Imperial College London has showed that small alterations to existing diabetes treatments can increase their effectiveness by changing their interactions with cells. Researchers tested a modified version of a type 2 […]
Prothena is stopping the development of AL amyloidosis treatment NEOD001 following unfavorable results in the phase 2b Pronto study. The Phase 2b Pronto study did not meet its primary or secondary endpoints. A phase 3 […]
Scientists from the University of Lincoln in the UK have created a new technique using nanotechnology which can make drugs more effective at reaching their target. Scientists have devised a new technique to ‘decorate’ gold nanoparticles […]
Biogen has entered into a new ten-year collaboration agreement with Ionis Pharmaceuticals for the development of antisense drug candidates to treat a range of neurological diseases. The partnership will use Biogen’s expertise in neuroscience research […]